Skip to content

Observation of the effect of different doses of oliceridine on postoperative analgesia in elderly patients with laparoscopic colorectal cancer

Observation of the effect of ifferent doses of oliceridine on postoperative analgesia in elderly patients with laparoscopic colorectal cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091691
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

first:Mix 0.5mg/10ml fentanyl with 90ml physiological saline to 100ml. The loading amount is 4ml, followed by a patient-controlled analgesia regimen with a PCA dose of 2ml, a locking time of 6 minutes
second:Mix 10mg/10ml oliceridine with 90ml physiological saline to 100ml. Divide the load into two doses, 0.75 mg each time and a total of 1.5 mg, with a 10 minute interval between each dose
Afterwards, a patient-controlled analgesia plan was developed, with a PCA dose of 0.2mg or 2ml, a locking time of 6 minutes, and no background dose
third:Mix 10mg/10ml oliceridine with 90ml physiological saline to 100ml. Divide the load into two doses, 0.75 mg each time and a total of 1.5 mg, with a 10 minute interval between each dose
Afterwards, a patient-controlled analgesia plan was developed, with a PCA dose of 0.35mg or 3.5ml, a locking time of 6 minutes, and no background dose

Sponsors

People's Hospital of Tianjin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age range of 65-80 years old; 2) ASA levels I-III; 3) BMI 18.5-24.9; 4) Planned surgery for lower abdominal colorectal cancer under general anesthesia; 5) Accept postoperative patient-controlled intravenous analgesia pump (PCIA) treatment; 6) Having the ability to read and write;7) You can sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Severe liver and kidney dysfunction; 2) Patients with mental illnesses; 3) METs<4 patients; 4) Abuse of anesthesia and sedatives; 5) History of allergies to relevant drugs; 6) Emergency reoperation; 7) Post operative admission to ICU; 8) Participated in clinical research on other drugs or medical devices in the past 3 months; 9) Those determined by researchers to be ineligible for inclusion.

Design outcomes

Primary

MeasureTime frame
NRS rating;

Secondary

MeasureTime frame
consumption of analgesic drugs;Ramsay Sedation Rating;

Countries

China

Contacts

Public ContactDing Ling

People's Hospital of Tianjin

dingling720@163.com+86 189 0217 7280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026